RE:x sites, y patients, always underwhelming
The higher the "better than expectations result" during the test, the bigger the market/acceptance for the treatment once FDA approval is received.
Also, if the FDA doesn't stop the test at the mid point of 90 test participants, if the results of the test shows siginificant proof of exceeding expextations, then it's my belief that there is a good chance the FDA stop the test whan an additional 10 or 20 or 30 more people are enrolled in the test and assuming test results are still exceeding expectations.
Just because the test isn't stopped at the mid point, it doesn't mean that the test has to run to completion.
There is the possibility that the test shows exceeding epectations at the mid point, possily at the end of February, and the test continues to run and when another 15 or 20 test participants are enrolled with exceeding expectations results, the FDA may stop the test at that point???